Article ; Online: A Comprehensive narrative review of transcriptomics and epigenomics of gallbladder cancer.
Journal of cancer research and therapeutics
2024 Volume 19, Issue Suppl 2, Page(s) S499–S507
Abstract: Abstracts: Gallbladder cancer (GBC) is one of the quiet prevalent and aggressive biliary tract malignant neoplasms distinguished by significant cellular heterogeneity, metastatic activity, and a poor prognosis, with varied frequency worldwide. Most ... ...
Abstract | Abstracts: Gallbladder cancer (GBC) is one of the quiet prevalent and aggressive biliary tract malignant neoplasms distinguished by significant cellular heterogeneity, metastatic activity, and a poor prognosis, with varied frequency worldwide. Most cases are detected incidentally while routine screening imaging or pathological investigation of cholecystectomy tissues and usually present with advanced disease. The surgical resection is usually done in the initial clinical stage having limited spread. Despite the surgical therapy, the death rate is significant. Furthermore, the molecular mechanisms affecting the clinical course of inflammatory gallbladder to carcinogenesis remain poorly understood. There is an impending need for developing diagnostic biomarkers and targeted approaches for GBC. The newer molecular platform, such as next-generation sequencing (NGS), such as RNA-sequencing (RNAseq), single-cell sequencing, and microarray technology, has revolutionized the field of genomics, opened a new perspective in defining genetic and epigenetic characteristics identifying molecules as possible therapeutic targets. Therefore, in this review, we would analyze transcriptomic and epigenomics profiles of GBC using already published high-throughput sequencing-based studies published between 2010 and 2023. The review would also analyze the possible impact of the technological advancement on the patient management strategy and overall survival. This may also help identify target genes and pathways linked to GBC, which may help establish molecular biomarkers, for early GBC diagnosis, personalized therapy, and management. |
---|---|
MeSH term(s) | Humans ; Gallbladder Neoplasms/diagnosis ; Gallbladder Neoplasms/genetics ; Gallbladder Neoplasms/pathology ; Epigenomics ; Cholecystectomy ; Gene Expression Profiling ; Biomarkers |
Chemical Substances | Biomarkers |
Language | English |
Publishing date | 2024-02-21 |
Publishing country | India |
Document type | Review ; Journal Article |
ZDB-ID | 2187633-2 |
ISSN | 1998-4138 ; 0973-1482 |
ISSN (online) | 1998-4138 |
ISSN | 0973-1482 |
DOI | 10.4103/jcrt.jcrt_1823_23 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.